We exist so that no laboratory has to discard biology for the sake of a marker count, and so that every section reveals the full architecture of health or disease.
Phantom Sciences Began In A Harvard Medical School Lab, Where Our Founders Came Against Issues Of Time, Cost, Resolution and Flexibility For Mapping Proteins In Tissues. They Rebuilt The Imaging, The Chemistry and The Analysis Instead Of Accepting The Barriers.
Today Our Instruments, Reagents And Analysis Software Are Developed As A Flexible Affordable and Scalable System. That Discipline Is Why Multiplex Depth Arrives Without Compromising Quality.
Imaging Depth
that Holds Its Signal
Spatial proteomics is evolving from beautiful images to decision-grade tissue data that will power the next generation of advances in biology, clinical diagnosis and AI-powered discovery
The team behind the platform
Phantom Sciences is built by scientists and engineers who have spent their careers at the intersection of chemistry, optics, and pathology.
Dr. Jay Thiagarajah
Co-FounderPhysician-scientist and co-inventor of SPECTRE-Plex technology, whose work on optical methods and intestinal biology anchors our platform's roadmap, connecting tissue-level multiplexing to real clinical questions.
Dr. Michael Anderson
Co-FounderScientist and engineer and co-inventor of SPECTRE-Plex, with extensive expertise in imaging and device design who drives our technical and system development
Dr. Dan Chinnapen
Co-Founder & CEOSerial Drug hunter and biotech startup leader. Former Boston Children’s Hospital Assistant Professor and Biotechnology industry experience in VC-backed companies
Russell Ulbrich
Co-Founder & Head of Business Development>25 years in microscopy and imaging sales, distribution, product development, and customer adoption. Leads partnerships with imaging companies, biotech and pharma.